000 01282 a2200361 4500
005 20250515181054.0
264 0 _c20090803
008 200908s 0 0 eng d
022 _a1474-547X
024 7 _a10.1016/S0140-6736(09)61313-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoyd, Mark
245 0 0 _aAntiretroviral roll-out: the problem of second-line therapy.
_h[electronic resource]
260 _bLancet (London, England)
_cJul 2009
300 _a185-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAfrica
_xepidemiology
650 0 4 _aAntiretroviral Therapy, Highly Active
_xeconomics
650 0 4 _aDeveloped Countries
650 0 4 _aDeveloping Countries
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aGlobal Health
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aRetreatment
_xeconomics
650 0 4 _aTreatment Failure
650 0 4 _aWorld Health Organization
700 1 _aEmery, Sean
700 1 _aCooper, David A
773 0 _tLancet (London, England)
_gvol. 374
_gno. 9685
_gp. 185-6
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(09)61313-1
_zAvailable from publisher's website
999 _c19025881
_d19025881